Skip to main content

Are you Dr. Alavi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 34 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jane Alavi, MD is a hematologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1969 - 1971
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1968 - 1969
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Internal Medicine, 1967 - 1968
  • University of Virginia Medical Center
    University of Virginia Medical CenterInternship, Transitional Year, 1966 - 1967
  • Harvard Medical School
    Harvard Medical SchoolClass of 1966

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1971 - 2021

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Upcc8399: Oral Procarbazine In Treatment Of Recurrent High Grade AstrocytomaNational Center For Research Resources2000–2002
  • Upcc7399: Pyrazolacridine In Adults W Newly Diagnosed Glioblastoma MultiformeNational Center For Research Resources2000–2002
  • Pre-Irradiation 9-Amino-20(S)-Camptothecin In GlioblastoNational Center For Research Resources2000–2002
  • Continuous Exposure Oral Phenylbutyrate 3 Time Daily ScheduleNational Center For Research Resources1999–2002
  • New Approaches To Brain Tumor Therapy--A CNS ConsortiumNational Cancer Institute2001
  • Phase 1 Trial Of Hsvtk Gene Therapy For CNS TumorsNational Center For Research Resources1999–2000
  • Phase I Evaluation Of Phenylbutyrate In GliomaNational Center For Research Resources1998–1999
  • Phase 1 Trial Of Hsvtr Gene Therapy For CNS TumorsNational Center For Research Resources1997–1998
  • Phase I Trial Of Hsvtk Gene Therapy For CNS TumorsNational Cancer Institute1995–1997